©The Author(s) 2019.
World J Gastroenterol. Jul 7, 2019; 25(25): 3256-3267
Published online Jul 7, 2019. doi: 10.3748/wjg.v25.i25.3256
Published online Jul 7, 2019. doi: 10.3748/wjg.v25.i25.3256
Table 1 The baseline characteristics of the enrolled treatment-naïve chronic hepatitis B patients with normal or minimally raised alanine aminotransferase levels
| Characteristics (n = 63) | |
| Sex, male/female | 37/26 |
| Age, mean (± SD) yr | 50.8 (± 8.9) |
| Body mass index, mean (± SD) kg/m2 | 23.4 (± 3.4) |
| AST, mean (± SD), IU/L (normal 4-40 IU/L) | 43.5 (± 22.6) |
| ALT, mean (± SD), IU/L (normal 4-40 IU/L) | 44.0 (± 20.8) |
| Platelet counts, mean (± SD), × 103/mm3 | 163.5 (± 39.4) |
| Prothrombin time, mean (± SD), INR | 1.05 (± 0.08) |
| Total bilirubin, mean (± SD), mg/dL | 0.75 (± 0.47) |
| Albumin, mean (± SD), g/dL | 3.97 (± 0.24) |
| γ-glutamyl transferase, mean (± SD), U/L | 47.5 (± 31.0) |
| HBeAg status, positive/negative | 35/28 |
| HBV-DNA, mean (± SD), log10 IU/mL | 5.78 (± 1.64) |
| Grade of inflammatory activity (0/1/ 2/3) | 9/26/15/13 |
| Fibrosis stage (0/1/2/3 /4) | 3/16/14/ 14/16 |
- Citation: Park HS, Choe WH, Han HS, Yu MH, Kim YJ, Jung SI, Kim JH, Kwon SY. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study. World J Gastroenterol 2019; 25(25): 3256-3267
- URL: https://www.wjgnet.com/1007-9327/full/v25/i25/3256.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i25.3256